 |
|
| Related Stories |
|
|
|
|
| Sub-standard drug products recalled in Hong Kong |
|
|
The Department of Health (DH) of the Hong Kong government urged Monday members of the public not to buy and use 237 pharmaceutical products manufactured by an Australian firm named Pan Pharmaceuticals.
The plea followed the suspension of the license of the firm, also known as Pan Laboratories, and the cancellation of the registration of all pharmaceutical products manufactured by the firm by the Therapeutic Goods Administration (TGA), which is the drug regulatory authority of Australia.
During recent inspections by TGA inspectors, the manufacturer was found to have significant deficiencies related to the manufacture and quality control of pharmaceutical products, the spokesman for the DH said.
The company is a manufacturer of over-the-counter pharmaceutical products, mainly multivitamins and minerals products. About 237 pharmaceutical products manufactured by the company were registered in Hong Kong.
"The importers of these products have been asked to immediately recall their products from the market within 14 days. They are also required to report to DH the amount of the products recalled and the suggested means of their disposal," the spokesman said.
"So far, we have no record of people feeling unwell after taking any one of these pharmaceutical products," the spokesman said, adding that people who might have taken these products are advised to consult their doctor if necessary.
He also reminded retailers to remove the products from their shelves and return them to the importers as soon as possible.
Source: Xinhua News Agency
|
|
|
|
